Publications by authors named "Hanifa Ammarguellat"
Article Synopsis
- Trifluridine/tipiracil (FTD/TPI) combined with oxaliplatin is being studied for its effectiveness and safety in patients with advanced gastric cancers who can't handle standard chemotherapy.
- The research aims to compare this combination treatment against the standard FOLFOX regimen, focusing on improving progression-free survival (PFS).
- The ongoing PRODIGE73-UCGI40-LOGICAN trial includes 118 patients and will provide valuable insights into treatment options for HER2 negative gastric cancer in a first-line setting.
Article Synopsis
- The study looked at how doctors treat a type of brain cancer called primary central nervous system lymphoma (PCNSL) using radiation therapy.
- Researchers checked the records of 79 patients who had this treatment between 2011 and 2018, and found that many doctors didn’t follow the recommended radiation doses and areas that should be treated.
- The study suggests that doctors should better follow guidelines for radiation to help patients survive longer and avoid cancer coming back, and they recommend updating these guidelines.
Aim: Neoadjuvant chemotherapy has proven valuable in locally advanced resectable colon cancer (CC) but its effect on oncological outcomes is uncertain. The aim of the present paper was to report 3-year oncological outcomes, representing the secondary endpoints of the PRODIGE 22 trial.
Method: PRODIGE 22 was a randomized multicentre phase II trial in high-risk T3, T4 and/or N2 CC patients on CT scan.
Optimal treatment of non operable localized non small cell lung carcinoma (NSCLC) continues to evolve. Increasing overall survival must evolute through improving local tumoral control and eradication of probable occult metastasis. Historically, median survival varies between 7 and 10 months with a standard conventional fractionated radiotherapy (RT).
View Article and Find Full Text PDF